Wang Yanqiang | Atherosclerosis | Best Researcher Award

Posted on 17/03/202517/03/2025 by Pencis

Prof. Wang Yanqiang | Atherosclerosis | Best Researcher Award

Prof. Wang Yanqiang, Department of Neurology Ⅱ, The Affiliated Hospital of Shandong Second Medical University, China

Prof. Wang Yanqiang is a distinguished neurologist currently serving in the Department of Neurology II at the Affiliated Hospital of Shandong Second Medical University, China. With a strong academic background, Prof. Wang earned his Master’s degree in Neurology from Xu Zhou Medical University and a Ph.D. from Sun Yat-sen University. His research primarily focuses on the pathogenesis and neuroprotection of ischemic brain injury, Parkinson’s disease, and other cerebrovascular disorders. Over the years, Prof. Wang has held various key positions, including roles as a resident and attending doctor at leading medical institutions in China.

AUTHOR PROFILE

Orcid Profile

🎓EARLY ACADEMIC PURSUITS:

Prof. Wang Yanqiang began his academic journey in the field of neurology, focusing on understanding the intricacies of neurological disorders and brain function. He pursued his medical education and specialized in neurology, laying the foundation for his future contributions in this domain. His early academic training focused on acquiring deep knowledge of neurophysiology, clinical neurology, and neuroanatomy, which would later guide his professional endeavors.

🏥PROFESSIONAL ENDEAVORS:

Prof. Wang Yanqiang holds a distinguished position at the Department of Neurology II at The Affiliated Hospital of Shandong Second Medical University, China. Over the years, he has been a leading figure in both clinical practice and medical research. He has worked tirelessly in patient care, offering specialized neurological treatments and providing critical insights into various neurological conditions. His professional endeavors also include educating and mentoring students, fostering the next generation of neurologists, and playing a key role in advancing clinical practices within the medical community.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON Atherosclerosis

Prof. Wang Yanqiang’s research primarily revolves around neurological disorders, with a particular focus on neurodegenerative diseases, cerebrovascular disorders, and epilepsy. His contributions to the understanding of these diseases have led to significant advancements in both diagnostic techniques and treatment methodologies. His research also spans neuroplasticity, neuroinflammation, and neuroprotective strategies, aiming to develop better therapeutic approaches for patients suffering from neurological impairments. Additionally, Prof. Wang has contributed to the development of diagnostic tools that have improved clinical outcomes in neurology.

🌍IMPACT AND INFLUENCE:

Prof. Wang Yanqiang’s work has had a profound impact on the field of neurology in both China and internationally. His contributions to the understanding of complex neurological diseases have shaped modern clinical practices and research initiatives. His publications and research findings have influenced treatment protocols and inspired further studies in neurodegenerative and cerebrovascular diseases. As a prominent figure in neurology, Prof. Wang has served as a role model for younger neurologists, encouraging a new wave of innovative thinking and patient-centered care in neurology.

📚ACADEMIC CITATIONS AND RECOGNITION:

Prof. Wang Yanqiang’s research has been widely recognized and cited within the academic community. His articles and studies are frequently cited in major neurological journals, reflecting the significance of his work in advancing scientific knowledge in neurology. His contributions have earned him a reputation as a leading expert in the field, with many of his works becoming foundational references for ongoing research. His academic influence is evidenced not only by citations but also through his collaborations with prominent neurologists worldwide.

🌟LEGACY AND FUTURE CONTRIBUTIONS:

Prof. Wang Yanqiang’s legacy in the field of neurology is marked by his groundbreaking research, dedication to patient care, and commitment to advancing the field. His work has contributed to a better understanding of neurological diseases and has paved the way for innovative treatments. As the field of neurology continues to evolve, Prof. Wang’s influence will likely continue to shape future developments in both clinical practice and medical research. His legacy also includes the mentorship of future generations of neurologists, ensuring that his impact on the field will extend far beyond his career.

🚀CONCLUSION:

Prof. Wang Yanqiang is an esteemed neurologist whose research has greatly advanced our understanding of ischemic brain injury, Parkinson’s disease, and cerebrovascular disorders. With a rich academic background and extensive clinical experience, his contributions to neuroprotection and molecular mechanisms are highly impactful. Through his numerous publications, Prof. Wang has gained international recognition for his work, which continues to influence the field of neurology. His dedication to improving patient outcomes and advancing neurological research makes him a true leader in the medical community.

TOP NOTABLE PUBLICATIONS

Title: Inhibition of the cGAS–STING pathway: contributing to the treatment of cerebral ischemia-reperfusion injury
- Journal: Neural Regeneration Research
- Volume: 2025-07
- Year: 2025
Title: Exploring the Neuroprotective Effects of Lithium in Ischemic Stroke: A literature review
- Journal: International Journal of Medical Sciences
- Volume: 2024
- Year: 2024
Title: Risk Factors and Clinical Characteristics of First-ever Ischemic Stroke Caused by ICAS with Leukoaraiosis
- Journal: International Journal of Medical Sciences
- Volume: 2024
- Year: 2024
Title: 1,25-D3 ameliorates ischemic brain injury by alleviating endoplasmic reticulum stress and ferroptosis: Involvement of vitamin D receptor and p53 signaling
- Journal: Cellular Signalling
- Volume: 2024-10
- Year: 2024
Title: A case of acute basilar artery occlusion due to atherosclerotic disease revascularized by drug-coated balloon dilation
- Journal: International Journal of Neuroscience
- Volume: 2024-09
- Year: 2024
Title: A case report of drug-coated balloon dilation angioplasty in a patient with acute atherosclerotic basilar artery occlusion
- Journal: Asian Journal of Surgery
- Volume: 2024-09
- Year: 2024
Title: Global, regional, and national epidemiology of ischemic stroke from 1990 to 2021
- Journal: European Journal of Neurology
- Volume: 2024-09-17
- Year: 2024
Title: Genetic insights into the relationship between immune cell characteristics and ischemic stroke: A bidirectional Mendelian randomization study
- Journal: European Journal of Neurology
- Volume: 2024-05
- Year: 2024
Title: Assessing tobacco-related ischemic stroke in Pakistan (1990-2019): Insights from the Global Burden of Disease Study
- Journal: Tobacco Induced Diseases
- Volume: 2024-03-28
- Year: 2024
Title: First report of a p.Cys484Tyr Notch3 mutation in a CADASIL patient with acute bilateral multiple subcortical infarcts—case report and brief review
- Journal: BMC Neurology
- Year: 2024

Dong MA | Cardiovascular Researches | Best Researcher Award

Posted on 04/03/202504/03/2025 by Pencis

Prof. Dong MA | Cardiovascular Researches | Best Researcher Award

Prof. Dong MA, Hebei Medical University, China

Prof. Dong Ma is a distinguished professor at Hebei Medical University, China, specializing in medical sciences and healthcare innovations. With a strong academic background, he has made significant contributions to biomedical research, clinical studies, and medical advancements. His work focuses on developing new treatments, improving patient care, and enhancing healthcare methodologies. Prof. Ma’s research is widely cited in prestigious medical journals, influencing global healthcare policies and practices. As a mentor and scholar, he continues to inspire future medical professionals while fostering international research collaborations. His dedication to medical excellence and innovation ensures a lasting impact in the field.

AUTHOR PROFILE

Scopus Profile

🎓 EARLY ACADEMIC PURSUITS:

Prof. Dong Ma embarked on his academic journey with a strong foundation in medical sciences. He pursued his education in China, demonstrating exceptional aptitude in the field of medicine and research. His early academic years were marked by rigorous studies, participation in innovative projects, and a keen interest in medical advancements.

🏛️ PROFESSIONAL ENDEAVORS:

Prof. Ma is currently a distinguished professor at Hebei Medical University, China. Throughout his career, he has been actively involved in teaching, mentoring, and guiding students in medical sciences. His professional engagements extend beyond the classroom, contributing to the university’s research and global collaborations in medical research and healthcare advancements.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR RESEARCHES:

Prof. Ma’s research primarily revolves around medical sciences, healthcare innovations, and clinical applications. His work includes:

Biomedical Research: Investigating novel treatments and technologies in the medical field.
Clinical Studies: Conducting evidence-based research to improve patient care and treatment outcomes.
Medical Innovations: Developing and contributing to new methodologies and technologies in healthcare.

His dedication to research has significantly impacted both theoretical knowledge and practical medical applications, benefiting healthcare professionals and patients alike.

🌍 IMPACT AND INFLUENCE:

Prof. Ma’s contributions have made a profound impact on the medical community. His research has been cited extensively in academic journals, influencing policies and practices in the field of medicine. His work has also led to collaborations with international medical institutions, further amplifying his influence on global healthcare development.

📖 ACADEMIC CITATIONS:

Prof. Ma has been cited in numerous prestigious medical journals and research papers. His publications cover a wide range of topics, including:

Advances in medical treatments and techniques.
Healthcare policy improvements.
Breakthroughs in disease prevention and management.

His academic work serves as a valuable resource for researchers, scholars, and healthcare professionals worldwide.

🏅 LEGACY AND FUTURE CONTRIBUTIONS:

Prof. Dong Ma’s legacy is built upon his relentless pursuit of medical excellence. His future contributions are expected to:

Drive Innovation: Further enhance medical technologies and treatment approaches.
Inspire Future Scholars: Mentor upcoming medical professionals and researchers.
Expand Global Collaborations: Strengthen research ties with international institutions for broader healthcare advancements.

🔥 CONCLUSION:

Prof. Dong Ma stands as a visionary leader in medical sciences, shaping the future of healthcare through groundbreaking research, innovation, and education. His dedication to improving patient care, advancing medical treatments, and mentoring future professionals has left a lasting impact on both academia and clinical practice. With numerous contributions to medical research and extensive collaborations worldwide, he continues to drive progress in healthcare. His legacy is defined by excellence, knowledge, and a passion for medical advancements, ensuring a brighter, healthier future for generations to come.

TOP NOTABLE PUBLICATIONS

The Impact of the Monocyte-to-High-Density Lipoprotein Cholesterol Ratio on the Prognosis of Patients with Non-Viral,Non-Alcoholic Hepatocellular Carcinoma:a Retrospective Cohort Study

Authors: Xianzhe Lou, Tongguo Miao, Shiya Zhang, Dong Ma, Yuemin Nan

Journal: Chinese General Practice

Year: 2025

Combined DeRitis ratio and alkaline phosphatase on the prediction of portal vein tumor thrombosis in patients with hepatocellular carcinoma

Authors: Tongguo Miao, Shiya Zhang, Yunjing Zhang, Dong Ma, Yuemin Nan

Journal: Scientific Reports

Year: 2024

Study on the relationship between Methylation of Neuregulin (NRG) Gene and Cervical Carcinoma

Authors: Xizhao Yan, Fenglan An, Zhenzhen Ding, Dong Ma, Xiaohui Yang

Journal: Pakistan Journal of Medical Sciences

Year: 2024

α-HBDH is a superior to LDH in predicting major adverse cardiovascular events in patients with acute aortic dissection

Authors: Yunjing Zhang, Yue Sun, Yongbo Zhao, Dong Ma

Journal: Heliyon

Year: 2024

Monocyte-to-High-Density Lipoprotein-Cholesterol Ratio Predicts Prognosis of Hepatocellular Carcinoma in Patients with Metabolic-Associated Fatty Liver Disease

Authors: Tongguo Miao, Xianzhe Lou, Shiming Dong, Dong Ma, Yuemin Nan

Journal: Journal of Hepatocellular Carcinoma

Year: 2024

Litao Guo | Cardiac Rehabilitation | Best Researcher Award

Posted on 17/02/202517/02/2025 by Pencis

Prof. Litao Guo | Cardiac Rehabilitation | Best Researcher Award

Prof. Litao Guo, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

Prof. Litao Guo is a Deputy Director and Associate Chief Physician at The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China. With over 18 years of experience in intensive care medicine, he specializes in cardiopulmonary resuscitation (CPR), ECMO therapy, and critical patient management. Prof. Guo is also an expert in intelligent simulation teaching for emergency skills training. His research includes advanced ECMO treatments and innovative CPR training methods using intelligent simulation platforms. He has published 16 research papers, contributing significantly to critical care medicine and improving patient outcomes in high-risk medical situations.

AUTHOR PROFILE

Scopus Profile

🎓EARLY ACADEMIC PURSUITS:

Prof. Litao Guo embarked on his academic journey in intensive care medicine, where he spent more than 18 years developing his expertise. From a resident to an associate chief physician, he gained valuable experience and hands-on knowledge in managing critically ill patients. Prof. Guo has also served as a master tutor, fostering the next generation of healthcare professionals, particularly in cardiopulmonary resuscitation (CPR) and ECMO treatment. This foundation in intensive care provided him with a deep understanding of patient management and critical interventions.

💼PROFESSIONAL ENDEAVORS:

Currently, Prof. Guo serves as the Deputy Director and Associate Chief Physician at The First Affiliated Hospital of Xi’an Jiaotong University in Xi’an, China. His daily responsibilities include overseeing the treatment and management of critically ill patients, particularly those requiring advanced life-saving procedures such as ECMO and CPR. He plays a pivotal role in shaping clinical practices, guiding patient care, and contributing to the advancement of intensive care medicine. His leadership is integral to the hospital’s focus on improving patient outcomes in high-stakes medical situations.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIAC REHABILITATION:

Prof. Guo is widely recognized for his research on intelligent simulation teaching and training methods, particularly in CPR. His work involves leveraging cutting-edge technology to enhance the teaching and practical skills of medical staff in emergency procedures. He has been instrumental in developing an intelligent simulation platform to train teams in effective CPR techniques, emphasizing team coordination, division of labor, and the standing position during resuscitation efforts. Additionally, his research delves into the management of ECMO therapy, focusing on treating complications such as massive airway bleeding with early clamping and advanced intervention measures.

🌍IMPACT AND INFLUENCE:

Prof. Guo’s research and clinical contributions have had a significant impact on improving outcomes for critically ill patients. His work on ECMO combined with advanced airway management has been especially groundbreaking, offering new insights and techniques to reduce mortality rates. His intelligent simulation teaching platform is transforming the way first responders and healthcare professionals are trained, ensuring they are equipped with the best skills to save lives. Prof. Guo’s publications, including 16 relevant research papers, have gained widespread recognition within the medical community.

📚ACADEMIC CITATIONS:

Prof. Guo has published 16 research papers, many of which focus on innovative approaches to CPR and ECMO. His scholarly work has contributed to the growing body of knowledge in intensive care medicine, particularly in areas that directly affect patient survival in critical care settings. These publications are frequently cited by other researchers, underscoring the importance of his work in advancing medical practice.

🔮LEGACY AND FUTURE CONTRIBUTIONS:

Prof. Guo is dedicated to further advancing intensive care medicine through both his clinical practice and research endeavors. His focus on innovative training techniques and treatment protocols, such as ECMO and CPR management, ensures that future healthcare providers will be well-equipped to manage complex and life-threatening situations. His legacy will be one of continuous improvement in the fields of sepsis, resuscitation, and critical care, with lasting effects on the healthcare system and patient care outcomes.

🌟CONCLUSION:

Prof. Litao Guo’s work in intensive care medicine, particularly in cardiopulmonary resuscitation (CPR) and ECMO therapy, has had a profound impact on improving patient care and outcomes in critical settings. His pioneering research on intelligent simulation platforms for emergency training is revolutionizing medical education, ensuring better preparedness among healthcare teams. With over 18 years of experience and 16 published papers, his contributions continue to shape the field. Prof. Guo’s commitment to advancing both clinical practice and medical education ensures that his legacy will inspire future generations of healthcare professionals.

TOP NOTABLE PUBLICATIONS

Exploration of cardiopulmonary resuscitation teamwork training for maternal cardiac arrest using the SimMan intelligent simulation platform: A simulation teaching study

Authors: Zhang, Ruirui; Liu, Yu; Zhang, Mingming; Bai, Hongliang; Guo, Litao

Journal: Health Science Reports

Year: 2024

Regional Practice Variation and Outcomes in the Standard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI) Trial: A Post Hoc Secondary Analysis

Authors: Vaara, Suvi T.; Neto, Ary Serpa; Bellomo, Rinaldo; Yang, Yang; Padayachee, Laven

Journal: Critical Care Explorations

Year: 2024

Lingyan Chen | Cardiovascular Diseases | Best Researcher Award

Posted on 17/02/202517/02/2025 by Pencis

Dr. Lingyan Chen | Cardiovascular Diseases | Best Researcher Award

Dr. Lingyan Chen, Wenzhou Medical university, China

Dr. Lingyan Chen is an Associate Researcher at Wenzhou Medical University, China, specializing in mitochondrial quality control and disease pathogenesis. She holds a Ph.D. from Wenzhou Medical University (2019-2022) and completed a postdoctoral fellowship at Guangzhou Medical University (2019-2024). Her research focuses on gene knockout models, tumor studies, and cardiovascular pharmacology. She has received multiple awards, including honors from the Circulation Journal Awards (Japan) and the Zhejiang Society of Biochemistry. With extensive experience in molecular biology techniques, Dr. Chen continues to advance biomedical research, aiming to develop novel therapeutic strategies for metabolic and cardiovascular diseases.

AUTHOR PROFILE

Scopus Profile

🎓EARLY ACADEMIC PURSUITS:

Dr. Lingyan Chen embarked on her academic journey at Changsha Medical University, earning a B.Sc. degree (2006-2009). She then pursued a M.Sc. at The University of South China (USC) (2015-2018), where she focused on pathogenesis and prevention of atherosclerosis, supported by prestigious research grants. She completed her Ph.D. at Wenzhou Medical University (WMU) (2019-2022), concentrating on mitochondrial quality control and its implications for related diseases.

🏥PROFESSIONAL ENDEAVORS:

🔹 Guangzhou Medical University (Postdoctoral Researcher) (2019-2024) – Advanced research in mitochondrial pathogenesis and disease modeling.
🔹 Guangzhou Medical School (Assistant Professor) (2018) – Engaged in pharmacology research on cardiovascular diseases.
🔹 Guangzhou Medical University (Research Assistant) (2018) – Coordinated multi-institutional research projects and managed key laboratory operations.
🔹 The Second People’s Hospital of Changde (Pediatric Nurse) (2009-2015) – Provided clinical care for newborns and critically ill children, mentoring trainee nurses.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR DISEASES:

Dr. Chen’s research spans multiple domains in biomedical sciences, including:
✅ Mitochondrial Quality Control & Disease Mechanisms – Investigated gene knockout/knockin mice models, heterogeneous tumors, and disease modeling for liver cancer and diabetes.
✅ Cardiovascular Pharmacology – Conducted Western Blotting, qPCR, immunofluorescence, and genetic experiments on macrophage behavior.
✅ Atherosclerosis & Hypertriglyceridemia – Studied clinical patient data, serum sample analysis, and statistical evaluations to uncover disease mechanisms.

🌍IMPACT AND INFLUENCE:

Dr. Chen has significantly influenced mitochondrial pathogenesis and cardiovascular research, contributing valuable insights into gene expression, disease prevention, and targeted treatments. Her research findings have aided in therapeutic advancements, particularly in cardiovascular disorders and metabolic diseases.

📚ACADEMIC CITES & LEGACY:

Dr. Chen’s research has been published in top-tier scientific journals, earning citations in the fields of biochemistry, molecular biology, and cardiovascular medicine. Her work serves as a foundation for future studies in mitochondrial dysfunction and therapeutic innovations.

🚀FUTURE CONTRIBUTIONS & VISION:

As an Associate Researcher at Wenzhou Medical University (2025-Present), Dr. Chen continues her groundbreaking research in mitochondrial medicine and disease pathogenesis. She aims to:
🔹 Develop novel therapeutic strategies for cardiovascular and metabolic disorders.
🔹 Expand research on genetic and molecular mechanisms underlying disease progression.
🔹 Mentor the next generation of biomedical researchers and medical professionals.

🏆AWARDS AND HONORS:

🔹 2020 – Second Prize in the 16th Graduate Academic Competition, Wenzhou Medical University
🔹 2020 – Second Prize in the “Xinzhi” Youth Forum, Zhejiang Society of Biochemistry and Molecular Biology
🔹 2018 – Second Prize for Excellent Experimental Research Paper, Circulation Journal Awards (Japan)
🔹 2018 – Outstanding Communist of the University of South China
🔹 2017 – 3rd Prize, Young Investigator Oral Presentation, 14th National Conference on Atherosclerotic Diseases & China-Canada Symposium
🔹 2017 – Excellence Award, Young Investigator Oral Presentation, Cross-Strait Cardiovascular Science Symposium
🔹 2017 – 1st Scholarship, University of South China
🔹 2016 – 2nd Scholarship, University of South China
🔹 2015 – 2nd Scholarship, University of South China

🌟CONCLUSION:

Dr. Lingyan Chen’s dedication to biomedical research, particularly in mitochondrial quality control and cardiovascular pharmacology, has significantly contributed to understanding disease mechanisms and potential treatments. Her extensive experience in molecular biology, combined with numerous accolades and publications, underscores her impact in the scientific community. As she continues her research at Wenzhou Medical University, Dr. Chen remains committed to advancing medical science, mentoring future researchers, and developing innovative therapeutic strategies. Her work holds great promise for improving treatments for metabolic and cardiovascular diseases, making her a valuable figure in the field of biomedical research.

TOP NOTABLE PUBLICATIONS

Inhibition of mitochondrial OMA1 ameliorates osteosarcoma tumorigenesis

Authors: Chen, Lingyan; Chen, Dejian; Pan, Yiming; Zhang, Dawei; Xia, Xiaodan

Journal: Cell Death and Disease

Year: 2024

Ciclopirox drives growth arrest and autophagic cell death through STAT3 in gastric cancer cells

Authors: Chen, Lingyan; Chen, Dejian; Li, Jiwei; Lu, Xiaoang; Lu, Bin

Journal: Cell Death and Disease

Year: 2022

MicroRNA-377 inhibits atherosclerosis by regulating triglyceride metabolism through the DNA methyltransferase 1 in apolipoprotein E-knockout mice

Authors: Chen, Lingyan (First Author); Xia, Xiaodan; Zhao, Zhiwei; Gong, Dan; Ma, Xuefeng; Yu, Xuhui; Zhang, Qi; Wang, Shengqi; Dai, Xinyu; Zheng, Xianliang; Zhang, Dawei; Yin, Wende; Tang, ChaoKun

Journal: Circulation Journal

Year: 2018

Myocardin suppression increases lipid retention and atherosclerosis via downregulation of ABCA1 in vascular smooth muscle cells

Authors: Xia, Xiaodan; Yu, Xuhui; Chen, Lingyan (Co-first Author); Xie, Shuo; Feng, Yan; Yang, Rui; Zhao, Zhiwei; Li, Hui; Wang, Gang; Tang, ChaoKun

Journal: Biochimica et Biophysica Acta (BBA) – Molecular and Cell Biology of Lipids

Year: 2021

Heart shock protein 70 accelerates atherosclerosis by downregulating the expression of ABCA1 and ABCG1 through the JNK/Elk-1 pathway

Authors: Zhao, Zhiwei; Zhang, Min; Chen, Lingyan (Co-first Author); Gong, Dan; Xia, Xiaodan; Yu, Xuhui; Wang, Shengqi; Ou, Xue; Dai, Xinyu; Zheng, Xianliang; Zhang, Dawei; Tang, ChaoKun

Journal: Biochimica et Biophysica Acta

Year: 2018

Puerarin promotes ABCA1-mediated cholesterol efflux and decreases cellular lipid accumulation in THP-1 macrophages

Authors: Li, ChaoHui; Gong, Dan; Chen, Lingyan (Co-first Author); Zhang, Min; Xia, Xiaodan; Cheng, Hongping; Huang, Chen; Zhao, Zhiwei; Zheng, Xianliang; Tang, XueEr; Tang, ChaoKun

Journal: European Journal of Pharmacology

Year: 2017

IL-8 negatively regulates ABCA1 expression and cholesterol efflux via upregulating miR-183 in THP-1 macrophage-derived foam cells

Authors: Tang, XueEr; Li, Hui; Chen, Lingyan (Co-first Author); Xia, Xiaodan; Zhao, Zhiwei; Zheng, Xianliang; Zhao, GuoJun; Tang, ChaoKun

Journal: Cytokine

Year: 2019